(Reuters) - Eli Lilly plans to spend at least $27 billion to build four new manufacturing plants in the U.S., the drugmaker ...
More than 200,000 federal worker positions have been eliminated, and 75,000 employees have accepted buyouts since President ...
Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback